Pros and cons of corticosteroid therapy for COVID-19 patients

In December 2019, an outbreak of severe pneumonia was reported in Wuhan, China. Later described as COVID-19 (coronavirus disease 2019), this infection caused by a virus from the Coronaviridae family (SARS-CoV-2) has spread globally. Effective therapies for this new disease are urgently needed. In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattos-Silva, Paula, Felix, Nathane Santanna, Silva, Pedro Leme, Robba, Chiara, Battaglini, Denise, Pelosi, Paolo, Rocco, Patricia Rieken Macedo, Cruz, Fernanda Ferreira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351052/
https://www.ncbi.nlm.nih.gov/pubmed/32659271
http://dx.doi.org/10.1016/j.resp.2020.103492
Descripción
Sumario:In December 2019, an outbreak of severe pneumonia was reported in Wuhan, China. Later described as COVID-19 (coronavirus disease 2019), this infection caused by a virus from the Coronaviridae family (SARS-CoV-2) has spread globally. Effective therapies for this new disease are urgently needed. In this short communication, we will evaluate the use of corticosteroids as an adjunctive pharmacological therapy in the management of COVID-19 and describe its pros and cons in light of the latest available evidence.

Ejemplares similares